A Detroit Medical Center hospital has begun treating patients with the first gene therapy for beta-thalassemia, a rare blood ...

Children’s Hospital of Michigan has announced a breakthrough in gene therapy for beta thalassemia, offering a potential cure ...

Thalassemia continues to be a significant health challenge in India, but with advancements in healthcare, early diagnosis, ...

Prime Minister’s Youth Programme Chairman Rana Mashhood Ahmed Khan said on Monday that a vigorous awareness campaign was ...

Iron overload remains a significant challenge in the management of β-thalassemia. Early diagnosis and regular monitoring are crucial for preventing organ damage. While chelation therapy is the ...

Conditions such as alpha thalassemia major, where the fetus cannot produce adequate red blood cells ... The condition can ...

Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center ...

For those with beta-0 thalassemia, their condition is usually more severe, while beta+ thalassemia tends to be milder. Treatment and Care The main goal of treatment is to reduce painful episodes and ...

Mitapivat, the company’s lead PK activator, was previously granted FDA orphan drug designation for the treatment of PK deficiency, thalassemia, and sickle cell disease. Tebapivat is not approved for ...

Tebapivat, a novel pyruvate kinase activator, is being investigated for the treatment of anemia in patients with lower-risk ...

Genetic variability and sex-specific differences may play a role in sickle cell disease (SCD)-related pain; however, more ...

Nagpur: In a significant development, renowned paediatrician Dr Vinky Rughwani has been nominated to the National Medical ...